Association between myocarditis and antipsychotics other than clozapine: a systematic literature review and a pharmacovigilance study using VigiBase

References

• Shader RI. Some thoughts on pharmacovigilance and postmarketing surveillance. Clin Ther. 2016;38(12):2.
   Google Scholar
• de Leon J, Ruan CJ, Schoretsanitis G, et al. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89(4):200–214. • Clozapine review article explaining clozapine-induced myocarditis as a hypersensitivity drug reaction.
   Google Scholar
• Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45(9):789–796.
   Google Scholar
• Vesterby A, Pedersen JH, Kaempe B, et al. Pludselig død under behandling med klozapin (Leponex) [Sudden death during treatment with clozapine (Leponex)]. Ugeskr Laeger. 1980;142:170–171.
   Google Scholar
• Meeker JE, Herrmann PW, Som CW, et al. Clozapine tissue concentrations following an apparent suicidal overdose of Clozaril. J Anal Toxicol. 1992;16(1):54–56. • First description of eosinophilic myocarditis in clozapine-induced myocarditis.
   Google Scholar
• Chopra N, de Leon J. Clozapine-induced myocarditis may be associated with rapid titration: a case report verified with autopsy. Int J Psychiatry Med. 2016;51(1):104–115.
   Google Scholar
• Committee on Safety of Medicines. Myocarditis with antipsychotics: recent cases with clozapine (Clozaril). Curr Probl Pharmacovigililance. 1993;19:9–10. • First report from a drug agency on the association of clozapine with myocarditis.
   Google Scholar
• La Grenade L, Graham D, Trontell A. Myocarditis and cardiomyopathy associated with clozapine use in the United States. N Engl J Med. 2001;345(3):224–225.
   Google Scholar
• Coulter DM, Bate A, Meyboom RH, et al. Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study. BMJ. 2001;322(7296):1207–1209. •• Authors linked to the Uppsala Monitoring Centre studied VigiBase database and wrote a 2001 report that suggested the association of clozapine and other antipsychotics with myocarditis.
   Google Scholar
• De Las Cuevas C, Sanz EJ, Ruan CJ, et al. Clozapine-associated myocarditis in the World Health Organization’s pharmacovigilance database: focus on reports from various countries. Rev Psiquiatr Salud Ment. 2021 Jul 20: S1888-9891(21)00070-7. Epub ahead of print. DOI:10.1016/j.rpsm.2021.07.004.
   Google Scholar
• Bellissima BL, Tingle MD, Cicović A, et al. A systematic review of clozapine-induced myocarditis. Int J Cardiol. 2018;259:122–129.
   Google Scholar
• Siskind D, Sidhu A, Cross J, et al. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy. Aust N Z J Psychiatry. 2020;54(5):467–481.
   Google Scholar
• Ertuğrul A, Yağcıoğlu EA, Ağaoğlu E, et al. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: a re-analysis of a Turkish case series. Rev Psiquiatr Salud Ment. 2022. DOI:10.1016/j.rpsm.2021.10.003
   Google Scholar
• Koenig M, McCollum B, Spivey JK, et al. Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases. Neuropsychopharmacol Hung. 2022;in press.
   Google Scholar
• de Leon J, Schoretsanitis G, Smith RL, et al. An international adult guideline for making clozapine titration safer by using 6 ancestry-based personalized dosing titrations, CRP and clozapine levels. Pharmacopsychiatry. 2022. DOI:10.1055/a-1625-6388
   Google Scholar
• Golpour A, Patriki D, Hanson PJ, et al. Epidemiological impact of myocarditis. J Clin Med. 2021;10(4):603.
   Google Scholar
• Worm K, Kringsholm B, Steentoft A. Clozapine cases with fatal, toxic or therapeutic concentrations. Int J Legal Med. 1993;106(3):115–118.
   Google Scholar
• Zhang HG. One case of pulmonary edema and myocarditis caused by clozapine toxicity. J Rare Uncommon Dis. 2001;8:49–50. In Chinese.
   Google Scholar
• Flanagan RJ, Spencer EP, Morgan PE, et al. Suspected clozapine poisoning in the UK/Eire, 1992–2003. Forensic Sci Int. 2005;155(2–3):91–99.
   Google Scholar
• Ye X, Shi C, Shen YW, et al. Forensic analysis of 24 Cases of long-term antipsychotics use-induced sudden unexpected deaths. Fa Yi Xue Za Zhi. 2018;34(6):644–647.
   Google Scholar
• Ruan CJ, de Leon J. Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine? Pharmacogenomics. 2020;21(6):369–373.
   Google Scholar
• Raedler TJ. Cardiovascular aspects of antipsychotics. Curr Opin Psychiatry. 2010;23(6):574–581.
   Google Scholar
• Llorca PM, Pere JJ. Leponex, 10 ans après – Une revue clinique [Leponex, 10 years after – a clinical review]. Encephale. 2004;30(5):474–491. French.
   Google Scholar
• Belhani D, Frassati D, Mégard R, et al. Cardiac lesions induced by neuroleptic drugs in the rabbit. Exp Toxicol Pathol. 2006;57(3):207–212.
   Google Scholar
• Hebebrand J. Neuroleptikanebenwirkungen mit Schwerpunkt Gewichtszunahme [Neuroleptic adverse effects with emphasis on weight gain]. Z Kinder Jugendpsychiatr Psychother. 2009;37(4):321–324. German.
   Google Scholar
• No authors. Quetiapine and cardiac muscle disorders. Prescrire Int. 2013;22(140):184.
   Google Scholar
• Lang UE, Willbring M, Von Golitschek R, et al. Clozapine-induced myocarditis after long-term treatment: case presentation and clinical perspectives. J Psychopharmacol. 2008;22(5):576–580.
   Google Scholar
• Rosenfeld AJ, Gibbs T, Ivie R, et al. Successful clozapine retrial after suspected myocarditis. Am J Psychiatry. 2010;167(3):350–351.
   Google Scholar
• Christoffersen RK, Vestergård LD, Høimark L, et al. Eosinofil myokarditis og pludselig uventet død hos en yngre patient behandlet med psykofarmaka [Eosinophilic myocarditis and sudden unexpected death in a younger patient treated with antipsychotics]. Ugeskr Laeger. 2011;173(44):2799–2800. Danish.
   Google Scholar
• Vang T, Rosenzweig M, Bruhn CH, et al. Eosinophilic myocarditis during treatment with olanzapine - report of two possible cases. BMC Psychiatry. 2016;16:70.
   Google Scholar
• Chen L, Tan P, Tan X. Case report of eosinophilia induced by quetiapine. Shanghai Arch Psychiatry. 2015;27(6):374–377.
   Google Scholar
• Kamali M, Pegg S, Janos JA, et al. Illness stage and predominant polarity in bipolar disorder:correlation with burden of illness and moderation of treatment outcome. J Psychiatr Res. 2021;140:205–213.
   Google Scholar
• Zipris P, Melamed Y, Weizman A, et al. Clozapine-induced eosinophilia and switch to quetiapine in a patient with chronic schizophrenia with suicidal tendencies. Isr J Psychiatry Relat Sci. 2007;44(1):54–56.
   Google Scholar
• Munjal S, Ferrando S. Myocarditis in a patient on clozapine: what did it? Clin Schizophr Relat Psychoses. 2018;12(2):89–91.
   Google Scholar
• Nachmani Major N, Dawson Bpharm Hons JL, Clark SR. Implementation and outcomes of a clozapine-associated myocarditis screening program in a region of South Australia-lessons learned. J Clin Psychopharmacol. 2020;40(3):250–258.
   Google Scholar
• Roesch-Ely D, Van Einsiedel R, Kathöfer S, et al. Myocarditis with quetiapine. Am J Psychiatry. 2002;159(9):1607–1608.
   Google Scholar
• Wassef N, Khan N, Munir S. Quetiapine-induced myocarditis presenting as acute STEMI. BMJ Case Rep. 2015;2015:bcr2014207151. •• Probable quetiapine-induced myocarditis after 3 weeks of a non-reported dose.
   Google Scholar
• Gosselin M, Dazé Y, Mireault P, et al. Toxic myocarditis caused by Acetaminophen in a multidrug overdose. Am J Forensic Med Pathol. 2017;38(4):349–352.
   Google Scholar
• Bhogal S, Ladia V, Paul TK. Quetiapine-associated myopericarditis. Am J Ther. 2018;25(5):e578–e579. •• Probable quetiapine-induced myocarditis after 5 days of starting a high dose (300 mg/day) with no titration.
   Google Scholar
• Giuntoli L, Dalmastri V, Cilloni N, et al. Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent. Int J Artif Organs. 2019;42(9):516–520.
   Google Scholar
• Hagiwara H, Fukushima A, Iwano H, et al. Refractory cardiac myocarditis associated with drug rash with eosinophilia and systemic symptoms syndrome due to anti-bipolar disorder drugs: a case report. Eur Heart J Case Rep. 2018;2(4):yty100.
   Google Scholar
• De Berardis D, Fornaro M, Orsolini L, et al. Clozapine-related sudden pericarditis in a patient taking long acting aripiprazole and valproate: a case report. Clin Psychopharmacol Neurosci. 2018;16(4):505–507.
   Google Scholar
• Friedrich ME, Winkler D, Konstantinidis A, et al. Cardiovascular adverse reactions during antipsychotic treatment: results of AMSP, a drug surveillance program between 1993 and 2013. Int J Neuropsychopharmacol. 2020;23(2):67–75.
   Google Scholar
• Lim X, Tibrewal P, Dhillon R, et al. Can asenapine cause myocarditis? Asian J Psychiatr. 2015;14:78–79.
   Google Scholar
• Wildbolz A. Fehldiagnosen durch einseitige psychiatrische oder einseitige somatische Beurteilung [Diagnostic errors due to unilateral psychiatric or unilateral somatic appreciation (author’s transl)]. Schweiz Rundsch Med Prax. 1979;68(45):1482–1487. German.
   Google Scholar
• Koutkias VG, A L-LL, Jaulent MC. Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies. Expert Opin Drug Saf. 2017;16(2):113–124.
   Google Scholar
• Cohen R, Lysenko A, Mallet T, et al. A case of clozapine-induced myocarditis in a young patient with bipolar disorder. Case Rep Cardiol. 2015;2015:283156.
   Google Scholar
• Bhatia MS, Gupta R, Dhawan J. Myocarditis after overdose of conventional antipsychotics. World J Biol Psychiatry. 2009;10(4 Pt 2):606–608.
   Google Scholar
• Ansari A, Maron BJ, Berntson DG. Drug-induced toxic myocarditis. Tex Heart Inst J. 2003;30(1):76–79.
   Google Scholar
• Hoehns JD, Fouts MM, Kelly MW, et al. Sudden cardiac death with clozapine and sertraline combination. Ann Pharmacother. 2001;35(7–8):862–866.
   Google Scholar
• Jahołkowski P, Niewiadomska J, Wciórka J, et al. Clozapine-induced myocarditis during co-administration of valproate: a case report. Psychiatr Pol. 2019;53(5):997–1002.
   Google Scholar
• Marder SR, Essock SM, Miller AL, et al. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161(8):1334–1349.
   Google Scholar
• Sawicke L, Sturla S. Efectos adversos cardíacos potencialmente letales causados por psicofármacos [Potentially lethal cardiac side effects caused by psychiatric drugs]. Vertex. 2008;19(82):387–393. Spanish.
   Google Scholar
• Nikolić-Kokić A, Tatalović N, Nestorov J, et al. Clozapine, ziprasidone, and sertindole-induced morphological changes in the rat heart and their relationship to antioxidant enzymes function. J Toxicol Environ Health A. 2018;81(17):844–853.
   Google Scholar
• Mackin P. Cardiac side effects of psychiatric drugs. Hum Psychopharmacol. 2008;23(Suppl 1):3–14.
   Google Scholar
• Von Olderhausen H, Wiek K. Zur klinik der agranulozytise (on the clinical aspects of agranulocytosis). Med Klin. 1964;59:50–55. German.
   Google Scholar
• Clifton B. Hypotension associated with tetanus. Lancet. 1964;1(7337):785–788.
   Google Scholar
• Santhanakrishnan BR, Balagopal Raju V. Management of scorpion sting in children. J Trop Med Hyg. 1974;77(6):133–135.
   Google Scholar
• Abidi S, Bhaskara SM. From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician’s dilemma. Can J Psychiatry. 2003;48(11):749–755.
   Google Scholar
• Paglini-Oliva P, Fernández AR, Fretes R, et al. Structural, ultrastructural studies and evolution of Trypanosoma cruzi-infected mice treated with thioridazine. Exp Mol Pathol. 1998;65(2):78–86.
   Google Scholar
• Buckley NA, Sanders P. Cardiovascular adverse effects of antipsychotic drugs. Drug Saf. 2000;23(3):215–228.
   Google Scholar
• Mendonça AAS, Gonçalves-Santos E, Souza-Silva TG, et al. Could phenothiazine-benznidazole combined chemotherapy be effective in controlling heart parasitism and acute infectious myocarditis? Pharmacol Res. 2020;158:104907.
   Google Scholar
• Jaffe CM. First-degree atrioventricular block during lithium carbonate treatment. Am J Psychiatry. 1977;134(1):88–89.
   Google Scholar
• Goren N, Leiros CP, Sterin-Borda L, et al. Nitric oxide synthase in experimental autoimmune myocarditis dysfunction. J Mol Cell Cardiol. 1998;30(11):2467–2474.
   Google Scholar
• Erley J, Goldsborough S, VandenBerg A, et al. Loxapine in patient with clozapine-resistant psychosis. Ment Health Clin. 2021;11(4):263–266.
   Google Scholar
• Norén GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22(1):57–69.
   Google Scholar
• Streiner DL. Statistics commentary series: commentary #14--confidence intervals. J Clin Psychopharmacol. 2016;36(3):198–199.
   Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245.
   Google Scholar
• Sheikh H, Siddiqui M, Uddin SMM, et al. The clinicopathological profile of eosinophilic myocarditis. Cureus. 2018;10(12):e3677.
   Google Scholar
• KhabazianZadeh F, Kazemi T, Nakhaee S, et al. Acetaminophen poisoning-induced heart injury: a case-based review. Daru. 2019;27(2):839–851.
   Google Scholar
• Kanno K, Sakai H, Yamada Y, et al. Drug-induced hypersensitivity syndrome due to minocycline complicated by severe myocarditis. J Dermatol. 2014;41(2):160–162.
   Google Scholar
• Yangui F, Zaiem A, and Antit S, et al. Acute myocarditis during carboplatin and pemetrexed chemotherapy for lung adenocarcinoma. Therapie. 2021;76(5):486–488.
   Google Scholar
• Guinart D, Correll CU. Antipsychotic polypharmacy in schizophrenia: why not? J Clin Psychiatry. 2020;81(3):19ac13118.
   Google Scholar
• Pae CU. Antipsychotic polypharmacy in treatment of schizophrenia; should or should not? Chonnam Med J. 2020;56(3):157–165.
   Google Scholar
• Gallego JA, Bonetti J, Zhang J, et al. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012;138(1):18–28.
   Google Scholar
• Faries D, Ascher-Svanum H, Zhu B, et al. Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics. BMC Psychiatry. 2005;5:26.
   Google Scholar
• Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169–179.
   Google Scholar
• Grande I, Berk M, Birmaher B, et al. Bipolar disorder. Lancet. 2016;387(10027):1561–1572.
   Google Scholar
• Maglione M, Maher AR, Hu J, et al. Off-label use of atypical antipsychotics: an update [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep. Report No.: 11-EHC087-EF. PMID: 22132426.
   Google Scholar
• National Association of State Mental Health Program Directors. Technical report on psychiatric polypharmacy. Alexandria (Virginia): Medical Directors Council and State Medicaid Directors; 2001.
   Google Scholar
• Spina E, Hiemke C, de Leon J. Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2016;12(4):407–422.
   Google Scholar
• de Leon J. Future studies on the interaction between clozapine and valproic acid should aspire to include longitudinal designs and free valproate concentrations, and should consider that inducer and/or inhibitory effects may vary with time, the individual, and the auto-induction of valproic acid. Ther Drug Monit. 2020;42(1):159–161.
   Google Scholar
• Ronaldson KJ, Fitzgerald PB, Taylor AJ, et al. Rapid clozapine dose titration and concomitant sodium valproate increase the risk of myocarditis with clozapine: a case-control study. Schizophr Res. 2012;141(2–3):173–178.
   Google Scholar
• Turra BO, Barbisan F, Azzolin VF, et al. Unmetabolized quetiapine exerts an in vitro effect on innate immune cells by modulating inflammatory response and neutrophil extracellular trap formation. Biomed Pharmacother. 2020;131:110497.
   Google Scholar